This technology has been used to measure total HER2 receptor and HER2 homodimer levels in breast tumor FFPE specimens [10], [28] and several studies have demonstrated the clinical utility of these measurements [11], [12], [28]. The gene discussed is ERBB2; the disease is breast neoplasm.